|
BR122021024397A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR112019008823A2
(enExample)
|
|
|
|
BR112020006084A8
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003520A2
(enExample)
|
|
|
|
BR112020008820A2
(enExample)
|
|
|
|
BR202017020981U2
(enExample)
|
|
|
|
BR202017006953U2
(enExample)
|
|
|
|
BR202017004898U2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN303997240S
(enExample)
|
|
|
|
CN303892650S8
(enExample)
|
|
|
|
CN303998551S
(enExample)
|
|
|
|
CN303997685S
(enExample)
|
|
|
|
CN303795867S9
(enExample)
|
|
|
|
CN304001237S
(enExample)
|
|
|
|
CN303995875S
(enExample)
|
|
|
|
CN303995443S
(enExample)
|
|
|
|
CN303991389S
(enExample)
|
|
|
|
CN303840916S8
(enExample)
|
|
|